United Therapeutics (UTHR) Ranks 1st in Renaissance Technologies 2026 List

Published on · Source: finance.yahoo.com

United Therapeutics (UTHR) Ranks 1st in Renaissance Technologies 2026 List

AI Summary

Summarized by AI from the source below

United Therapeutics Corporation (UTHR) is ranked 1st on Renaissance Technologies' list of top stocks for 2026. The fund disclosed its initial stake of 261,000 shares in UTHR in Q4 2010. As of Q1 2026, Renaissance owns nearly 1.8 million shares, a decrease of over 6% from Q4 2025. The company is preparing major NDA submissions to the FDA for Tyvaso, which aims to be the first inhaled anti-fibrotic treatment for Idiopathic Pulmonary Fibrosis, following positive data from its TETON studies.

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.

Share:

Get the weekly market brief

One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.

Get stories like this as they break

Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.

© 2026 NewsStocks.liveTermsPrivacy